Drugs / Allicin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00455416 | Apr 2007 → Apr 2009 | follicular lymphoma | Oslo University Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07812688 | Apr → Jun 2024 | — | Guangxi Normal University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allicin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00455416 ↗ |
| Known as | Diallyl thiosulfinate | ChEMBL registry synonym — accepted as the source's own label CHEMBL359965 ↗ |
| Modality | Small molecule | — CHEMBL359965 ↗ |